Wuhan Hvsen Biotechnology Co.,Ltd. (SHE:300871)

Wuhan Hvsen Biotechnology Revenue

Wuhan Hvsen Biotechnology had revenue of 406.71M CNY in the quarter ending June 30, 2026, a decrease of -3.88%. This brings the company's revenue in the last twelve months to 1.72B, up 8.68% year-over-year. In the year 2025, Wuhan Hvsen Biotechnology had annual revenue of 1.68B with 40.07% growth. That makes Wuhan Hvsen Biotechnology the 15,574th largest company in the world by revenue and 2,788th in China.

• Revenue (ttm): 1.72B
• Revenue Growth: +8.68%
• P/S Ratio: 2.33
• Revenue / Employee: 1.52M
• Employees: 1,133
• Market Cap: 3.98B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.68B	480.92M	40.07%
Dec 31, 2024	1.20B	180.57M	17.71%
Dec 31, 2023	1.02B	-3.14M	-0.31%
Jan 1, 2023	1.02B	26.68M	2.68%
Jan 1, 2022	996.22M	218.76M	28.14%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 11, 2026

Data Sources Report a data error